Empagliflozin (BI 10773) in Type Two Diabetes (T2D) Patients, Open Label Extension

Clinical trial NCT00881530 · COMPLETED

Trial details

NCT number: NCT00881530
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2009-03-01
Primary completion: 2011-05-01
Enrollment: 660

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.